Cargando…
Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226537/ https://www.ncbi.nlm.nih.gov/pubmed/37256021 http://dx.doi.org/10.2147/ITT.S421440 |
_version_ | 1785050597766987776 |
---|---|
author | Wiggins, Simmi Levit, Noah A |
author_facet | Wiggins, Simmi Levit, Noah A |
author_sort | Wiggins, Simmi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10226537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-102265372023-05-30 Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter] Wiggins, Simmi Levit, Noah A Immunotargets Ther Letter Dove 2023-05-25 /pmc/articles/PMC10226537/ /pubmed/37256021 http://dx.doi.org/10.2147/ITT.S421440 Text en © 2023 Wiggins and Levit. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Letter Wiggins, Simmi Levit, Noah A Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter] |
title | Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter] |
title_full | Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter] |
title_fullStr | Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter] |
title_full_unstemmed | Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter] |
title_short | Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter] |
title_sort | dupilumab treatment is not associated with increased risk of overall skin infections [letter] |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226537/ https://www.ncbi.nlm.nih.gov/pubmed/37256021 http://dx.doi.org/10.2147/ITT.S421440 |
work_keys_str_mv | AT wigginssimmi dupilumabtreatmentisnotassociatedwithincreasedriskofoverallskininfectionsletter AT levitnoaha dupilumabtreatmentisnotassociatedwithincreasedriskofoverallskininfectionsletter |